Patents by Inventor Ish KUMAR

Ish KUMAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroarylalkanoic acids as integrin receptor antagonists
    Publication number: 20020133023
    Abstract: The present invention relates to a class of compounds represented by the Formula I 1
    Type: Application
    Filed: June 15, 2001
    Publication date: September 19, 2002
    Inventors: Srinivasan Raj Nagarajan, Ish Kumar Khanna, Michael B. Tollefson, Scott B. Mohler, Barbara Chen, Mark Russell, Balekudru Devadas, Thomas D. Penning, Lori A. Schretzman, Dale P. Spangler, Mark Laurence Boys, Nizal Samuel Chandrakumar, Hung-Fun Lu
  • Dihydrostilbene alkanoic acid derivatives
    Publication number: 20020099209
    Abstract: The present invention relates to a class of compounds represented by the Formula 1.
    Type: Application
    Filed: June 15, 2001
    Publication date: July 25, 2002
    Inventors: Thomas Rogers, Michael Clare, Hwang-Fun Lu, Mark Russell, James W. Malecha, Ish Kumar Khanna, Thomas Penning, Srinivasan Raj Nagarajan
  • Cycloalkyl alkanoic acids as integrin receptor antagonists
    Publication number: 20020077321
    Abstract: The present invention relates to a class of compounds represented by the Formula I 1
    Type: Application
    Filed: June 15, 2001
    Publication date: June 20, 2002
    Inventors: Ish Kumar Khanna, Michael Clare, Alan F. Gasiecki, Thomas Rogers, Barbara Chen, Mark Russell, Hwang-Fun Lu
  • Bicyclic alphavbeta3 antagonists
    Publication number: 20020072518
    Abstract: The present invention relates to a class of compounds represented by the Formula I 1
    Type: Application
    Filed: August 29, 2001
    Publication date: June 13, 2002
    Inventors: Ish Kumar Khanna, Yi Yu, Balekudru Devadas, Hwang-Fun Lu, Nizal S. Chandrakumar, Renee M. Huff, Bipinchandra N. Desai, Srinivasan Raj Nagarajan
  • Purinylalkyl benzamide derivatives
    Patent number: 5861403
    Abstract: The present invention relates to compounds of the formula ##STR1## wherein HET is ##STR2## m is an integer from 1 to 4; R.sup.1 and R.sup.
    Type: Grant
    Filed: October 2, 1996
    Date of Patent: January 19, 1999
    Assignee: G. D. Searle & Co.
    Inventors: Ish Kumar Khanna, Richard Mathias Weier
  • Cinnamic acid derivatives
    Patent number: 5852210
    Abstract: The present invention relates to a class of compounds represented by the Formula I ##STR1## or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the .alpha..sub.v .beta..sub.3 integrin.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: December 22, 1998
    Assignee: G. D. Searle & Co.
    Inventors: Barbara B. Chen, Helen Y. Chen, Michael Clare, Stephen H. Docter, Ish Kumar Khanna, Francis Jan Koszyk, James W. Malecha, Julie Marion Miyashiro, Thomas D. Penning, Joseph G. Rico, Peter G. Ruminski, Mark A. Russell, Richard Mathias Weier, Xiangdong Xu, Stella S. Yu, Yi Yu
  • Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as inhibitors of 5-lipoxygenase
    Patent number: 5688822
    Abstract: Compounds of the formula: ##STR1## Formula I and the pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising a therapeutically-effective amount of the compounds or salts in combination with a pharmaceutically-acceptable carrier and methods for treating 5-lipoxygenase mediated conditions, inflammation-associated disorders and allergies.
    Type: Grant
    Filed: February 7, 1996
    Date of Patent: November 18, 1997
    Assignee: G.D. Searle & Co.
    Inventors: Ish Kumar Khanna, Michael Allan Stealey, Richard Mathias Weier
  • Pyrido-1,4-oxazinylalkyl-benzamide derivatives
    Patent number: 5652363
    Abstract: The present invention relates to compounds of the formula ##STR1## and pharmaceutical compositions containing a therapeutically effective amount of the compounds in combination with a pharmaceutically acceptable carrier and a method for treating diseases mediated by platelet activating factor.
    Type: Grant
    Filed: October 2, 1996
    Date of Patent: July 29, 1997
    Assignee: C.D. Searle & Co.
    Inventors: Ish Kumar Khanna, Michael Allan Stealey, Richard Mathias Weier